You are here

Daiichi Sankyo

Daiichi aims to double profits by 2013

Fierce Pharma

Fri, 03/12/10 - 11:24 am

Daiichi Sankyo Unit to Sell Generic Drugs

WSJ Online

Mon, 03/1/10 - 09:28 am

Daiichi Sankyo to enter Japan's generic drug market

Reuters

Fri, 02/26/10 - 10:49 am

Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug

Bloomberg

Mon, 02/1/10 - 09:58 am

Daiichi Sankyo' Subsidiary Acquires PharmaForce

Pharmaceutical Business Review

Wed, 01/6/10 - 11:13 am

Biotech drug approvals spiked in 2009

Fierce Biotech

Wed, 01/6/10 - 08:45 am

Daiichi Sankyo's CEO: Soft-talking revolutionary

FT.com

Mon, 11/30/09 - 10:36 am

Plavix Label Change: Good For Effient Now, Bad For Brands in the Long Run?

InVivo

Thu, 11/19/09 - 10:34 am

Bristol-Myers Squibb

Ranbaxy: FDA Issues Will Take Long Time To Resolve

WSJ Online

Mon, 11/9/09 - 11:26 am

Effient and Onglyza Start Slow—And That May Not Be A Bad Thing

InVivo

Mon, 10/26/09 - 11:58 am

Bristol-Myers Squibb

MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies

Bloomberg

Tue, 10/20/09 - 09:07 am

antibody discovery

Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study

WSJ Online

Fri, 10/2/09 - 10:40 am

Boston Scientific

Abbott Laboratories

Bristol-Myers Squibb

Study: Patients using Effient cost less

Fierce Pharma

Fri, 09/25/09 - 11:56 am

Japan's Daiichi Sankyo says new flu drug effective

Google/AFP

Mon, 08/10/09 - 09:58 am

Daiichi Sankyo Posts First-Quarter Loss on Ranbaxy

Bloomberg

Fri, 07/31/09 - 08:19 am

Is Lilly's Effient Sufficient?

CNBC

Mon, 07/13/09 - 11:48 am

How dangerous is Effient to Plavix?

Fierce Pharma

Mon, 07/13/09 - 11:29 am

Daiichi Sankyo Rises as FDA Approves Anti-Clot Drug

Bloomberg

Mon, 07/13/09 - 08:59 am

Blood Thinner's Approval A Muted Win For Lilly

Forbes

Sat, 07/11/09 - 08:53 am

Daiichi Sankyo Seeks Biotechnology, Cardiovascular Takeovers

Bloomberg

Wed, 06/10/09 - 04:38 am

Pages